Impact of respiratory syncytial virus on Streptococcus pneumoniae resistance to β-lactam antibiotics: an investigative study in children

Impact of respiratory syncytial virus on Streptococcus pneumoniae resistance to β-lactam antibiotics: an investigative study in children

Abstract Background This study characterizes the molecular interplay between respiratory syncytial virus (RSV) glycoproteins (G/F) and Streptococcus pneumoniae (S.pn) penicillin-binding proteins (PBPs), while evaluating RSV’s potential role in modulating S.pn β-lactam resistance. Methods Protein doc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lu Li, Yushun Wan, Yuncheng Wang, Ye Tao, Xiao Long, Enmei Liu, Yu Deng
Format:	Article
Language:	English
Published:	BMC 2025-06-01
Series:	BMC Microbiology
Subjects:	Respiratory syncytial virus Streptococcus pneumoniae Antibiotic resistance Glycoprotein Penicillin-binding protein
Online Access:	https://doi.org/10.1186/s12866-025-04066-5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bacteriophage-derived endolysins restore antibiotic susceptibility in β-lactam- and macrolide-resistant Streptococcus pneumoniae infections
by: Niels Vander Elst, et al.
Published: (2025-05-01)

Lower respiratory tract co-infection of Streptococcus pneumoniae and respiratory syncytial virus shapes microbial landscape and clinical outcomes in children
by: Xiaoran Yu, et al.
Published: (2025-06-01)

Detection of pbp2b and ermB genes in clinical isolates of Streptococcus pneumoniae
by: Navindra Kumari, et al.
Published: (2008-06-01)

Diagnosis of Community-Acquired Pneumonia Due to Influenza or Respiratory Syncytial Virus: Evaluation of RT-PCR Sensitivity in Nasopharyngeal, Saliva, and Sputum Samples
by: Julio Ramirez, et al.
Published: (2025-04-01)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
by: O. V. Muslimova, et al.
Published: (2022-07-01)

CLINICAL AND PATHOMORPHOLOGICAL MANIFESTATIONS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. CASE REPORT
by: I. V. Babachenko, et al.
Published: (2018-04-01)

SNP Polymorphism in Genomes of CC320 Isolates of Streptococcus pneumoniae Resistant to Beta-Lactams
by: I. A. Tzvetkova, et al.
Published: (2020-05-01)

Isolation and identification of Streptococcus pneumoniae that causes Respiratory Diseases
by: Shaymaa Habbaib Hassan AL Jowrani, et al.
Published: (2025-06-01)

Clonality of Streptococcus pneumoniae Isolates in Russia, Circulating from 1980 to 2017
by: I. A. Tsvetkova, et al.
Published: (2020-05-01)

Pharmacodynamic Evaluation of Adjuvant Targets: Low Molecular Weight PBP7/8 Effects on β-Lactam Activity Against Carbapenem-Resistant Acinetobacter Baumannii
by: Brian M. Ho, et al.
Published: (2025-06-01)

Molecular and biological characterization of <i>Streptococcus pneumoniae</i> isolates from patients with pneumococcal meningitis
by: Aida N. Chagaryan, et al.
Published: (2025-05-01)

The Impact of Palivizumab for Respiratory Syncytial Virus Prophylaxis on Preschool Childhood Asthma
by: Hannah Ora Hasson, et al.
Published: (2024-11-01)

Clinical behavior of Streptococcus pneumoniae meningoencephalitis Comportamiento clinico y terapéutico de la meningoencefalitis por Streptococcus pneumoniae
by: Raisa Bu-Coifiu Fanego, et al.
Published: (2009-12-01)

Effect of respiratory microflorae colonization on short and long‐time outcomes of respiratory syncytial virus infection in children: A scoping review
by: Lidan Gan, et al.
Published: (2024-12-01)

Beta‐Lactam Antibiotics Promote Extracellular Vesicle Production of Staphylococcus aureus Through ROS‐Mediated Lipid Metabolic Reprogramming
by: Xiaonan Huang, et al.
Published: (2025-05-01)

In vitro activity of macrolides against Streptococcus pneumoniae and Streptococcus pyogenes in the Russian Federation: “Status praesens”
by: Kozlov R.S., et al.
Published: (2024-09-01)

Association between Streptococcus pneumoniae And COVID-19 Co-infection in Patients with Severe Respiratory Diseases
by: Suhaib K. Ibrahim
Published: (2025-03-01)

Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain
by: Matilde Zornoza Moreno, et al.
Published: (2024-12-01)

Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants
by: Andreea Calomfirescu-Avramescu, et al.
Published: (2025-02-01)

Identification of cell wall binding domains and repeats in Streptococcus pneumoniae phage endolysins: A molecular and diversity analysis
by: Tahsin Khan, et al.
Published: (2024-12-01)

Streptococcus pneumoniae carriage and antibiotic use in children in southwestern Uganda
by: Birungi Mutahunga, et al.
Published: (2025-03-01)

ACUTE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN IN THE AGE ASPECT
by: V. B. Rovny, et al.
Published: (2015-08-01)

Improving the quality of care of respiratory syncytial virus in the neonatal and pediatric populations globally
by: Fungwe Jah, et al.
Published: (2025-05-01)

Generation of nanobodies against the F protein of respiratory syncytial virus and establishment of an indirect immunofluorescence assay
by: Qianqian Wang, et al.
Published: (2025-07-01)

Severity of Respiratory Viral Diseases and the Impacts of Underlying Medical Conditions During the Omicron Subvariant Dominant Epidemics—A Comparative Study of SARS-CoV-2, Influenza Virus and Respiratory Syncytial Virus
by: Yu Jung Choi, et al.
Published: (2025-05-01)

Determiation the antibacterial activity of Punicagranatum Extract towards Streptococcus Pneumonia and Klebsella Pneumonia
by: Ruaa Hassan Lateef
Published: (2019-04-01)

Antibiotic susceptibility testing and molecular characterization based on whole-genome sequencing of Streptococcus pneumoniae isolates from pediatric infections at the National Regional Medical Center of Southwest China during the COVID-19 pandemic
by: Ziyi Yan, et al.
Published: (2024-12-01)

Effectiveness of palivizumab immunoprophylaxis in infants with respiratory syncytial virus disease in Colombia
by: Juan Gabriel Piñeros, et al.
Published: (2021-11-01)

Predicting ICU Admission Risk in Children with Respiratory Syncytial Virus
by: Young Hwa Lee, et al.
Published: (2025-04-01)

Serotypes of Streptococcus pneumoniae causing major pneumococcal infections
by: Yu. V. Lobzin, et al.
Published: (2014-09-01)

Co-infection analysis of common respiratory pathogens in children with pneumonia in a hospital of Dongyang City, Zhejiang Province
by: LIANG Xueyao, et al.
Published: (2024-09-01)

In vitro susceptibility of a penicillin-resistant and tolerable isolate of Streptococcus pneumoniae to combination therapy
by: Arnab Majhi, et al.
Published: (2015-07-01)

Epidemiological and Clinical Characteristics of Respiratory Syncytial Virus Infection in Children in Hangzhou (2022–2023)
by: Qin-Rui Lai, et al.
Published: (2025-06-01)

Respiratory Syncytial Virus: What is the Risk Over 60?
by: Oğuzhan Acet, et al.
Published: (2024-12-01)

Description of respiratory syncytial virus genotypes circulating in Colombia
by: Viviana Avila, et al.
Published: (2018-12-01)

RESPIRATORY SYNCYTIAL VIRUS INFECTION: CLINICAL AND LABORATORY FEATURES
by: E. V. Mikhaylova, et al.
Published: (2017-07-01)

In-vitro antimicrobial activity of new antimicrobial agents against Streptococcus pneumoniae and potential resistance mechanisms: a multicenter study
by: Zichen Lei, et al.
Published: (2025-04-01)

Palivizumab for the Prophylaxis of Respiratory Syncytial Virus Disease: Expert Opinion and Recommendations for the Gulf Cooperation Council Region
by: Adel S. Alharbi, et al.
Published: (2024-09-01)

Epidemiology and genetic diversity of human respiratory syncytial virus in Belgium between 2011 and 2019
by: Kaat Ramaekers, et al.
Published: (2024-10-01)

Genetic diversity of penicillin-resistant Streptococcus pneumoniae
by: T. A. Savinova, et al.
Published: (2014-09-01)